Oral Solid Dosage Contract Manufacturing Market Global Trends, Market Share, Industry Size, Growth, Opportunities and Market Forecast – 2022 to 2028

The Global Oral Solid Dosage Contract Manufacturing Market is estimated to grow at a high CAGR of 5% during the forecast period of 2022-2028.

Large pharmaceutical companies are facing increasing research costs for new chemicals. To reduce these costs, companies are now focusing on outsourcing primary (API) and secondary (pharmaceutical) manufacturing. Outsourcing the secondary manufacturing of branded products reduces costs for innovators by approximately 40-60%. Innovators are looking for ways to expand operations, flexibility, and diversity in addition to reducing costs. Increased cost reduction efforts have significantly increased the demand for oral solid dosage contract manufacturing. On the other hand, CMOs’ growing focus on integrating into the pharmaceutical company’s value chain is also accelerating the demand for oral solid-dose contract manufacturing. CMOs are building dedicated facilities or capabilities for pharmaceutical companies that don’t prefer to build their own.

Market Segments

By Product

• Tablets
• Capsules
• Powders & Granules (MT)

By Release Mechanism

• Tablets
• Capsules
• Powders & Granules (MT)

By End User

• Big Pharma or Biotech
• Small & Medium Size Pharma or Biotech
• Emerging or Virtual Pharma
• Nutraceutical Companies

Key Players

• Thermo Fisher Scientific Inc. (Patheon N.V.)
• Lonza
• Catalent Inc.
• Alcami Corporation
• Halo Pharmaceutical Inc.
• CordenPharma International
• Arnet Pharmaceuticals
• Jubilant Life Sciences
• Pfizer Inc.

Scope of the Report

The research study analyzes the global Oral Solid Dosage Contract Manufacturing industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent Developments

o Market Overview and growth analysis
o Import and Export Overview
o Volume Analysis
o Current Market Trends and Future Outlook
o Market Opportunistic and Attractive Investment Segment

Geographic Coverage

o North America Market Size and/or Volume
o Latin America Market Size and/or Volume
o Europe Market Size and/or Volume
o Asia-Pacific Market Size and/or Volume
o Rest of the world Market Size and/or Volume

Key Questions Answered by Oral Solid Dosage Contract Manufacturing Market Report

1. What was the Oral Solid Dosage Contract Manufacturing Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2022-2028).

2. What will be the CAGR of Oral Solid Dosage Contract Manufacturing Market during the forecast period (2022-2028)?
3. Which segments (product type/applications/end-user) were most attractive for investments in 2022? How these segments are expected to grow during the forecast period (2022-2028).
4. Which manufacturer/vendor/players in the Oral Solid Dosage Contract Manufacturing Market was the market leader in 2020?
5. Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.